Emerald exiting Canada’s cannabis industry after losing over CA$200M
Emerald Health Therapeutics plans to exit Canada's recreational and medical cannabis sectors after racking up more than 200…
News December 2
Latest In: Emerald Health Therapeutics
Emerald pulls plug on affiliate’s federal cannabis license to decrease risk
British Columbia-based Emerald Health Therapeutics has requested that Health Canada not continue with a cannabis processing license for…
News December 27
Emerald Health Therapeutics buys Canadian cannabis grower for CA$90 million
British Columbia-based cultivator Emerald Health Therapeutics signed a deal worth 90 million Canadian dollars ($70 million) to buy…
News May 4
Sponsored
The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator
As cannabis shoppers become more educated, seed brands are no longer just selling genetics — they are shaping loyalty, discovery, and the next wave of premium cultivation culture.
June 9
Canadian cannabis companies ink deals for nearly CA$1B in funding in 10 days
Capital is pouring into the Canadian marijuana sector faster than ever, as companies prepare for the country’s anticipated…
News January 12
Canada’s Emerald Health Therapeutics inks pact to raise CA$15 million
Emerald Health Therapeutics signed a deal to raise 15 million Canadian dollars ($12 million) – funds the British…
News January 4
$770 million windfall: Canadian marijuana companies see surge in new investments
Canada’s marijuana-related companies collectively raised more than $770 million in the first half of 2017 – a nearly…
News August 1Featured
1
Latest Sponsored
